Blood tests can detect a wide range of drugs, from cannabis and cocaine to prescription medications and alcohol metabolites, but the detection window is generally shorter than urine or hair testing. For most substances, a blood draw captures drug use within hours to a few days, making it the preferred method when the question is whether someone is currently under the influence rather than whether they used something last week. The specifics, though, vary dramatically depending on the substance, the person’s metabolism, and how the lab runs the test.
Why Blood Is the Go-To for Recent Drug Use
Blood reflects what is actually circulating in your body right now. When a drug enters your bloodstream, the concentration rises quickly, peaks, and then falls as your liver metabolizes it and your kidneys filter out the byproducts. That real-time snapshot is why blood tests are considered the most reliable way to assess pharmacological effects and recent consumption.1Journal of Insights in Basic and Applied Sciences. A Comparative Study of Biological Samples (Blood, Urine, and Hair) Used in Forensic Laboratories for Drug Detection Urine, by contrast, catches metabolites that linger longer after use, making it better for routine workplace or clinical screening. Hair can document months of use history. Each matrix answers a different question, and blood’s niche is “what’s happening right now.”
That said, “right now” is relative. Some drugs vanish from blood within hours, while others leave detectable traces for days or even longer in certain users. The rest of this article breaks down the detection windows for the substances people ask about most, along with the variables that shift those timelines.
Detection Windows for Common Drug Classes
Most drugs follow a predictable arc in blood: rapid absorption, a peak, and then a decline governed by the drug’s half-life and how your body processes it. As a rough guide, here are the windows during which standard blood testing can pick up the most commonly screened substances:
- Cannabis (THC): A few hours for occasional users, but potentially days for heavy, frequent users.
- Cocaine: The parent drug clears within hours; metabolites like benzoylecgonine may be detectable for one to two days.
- Opioids: Generally detectable for about one to three days, depending on whether it is a short-acting drug like heroin or a longer-acting one like methadone.
- Amphetamines and methamphetamine: Roughly one to three days in blood.
- Benzodiazepines: Varies widely by specific drug, from hours for short-acting varieties to several days for long-acting ones.
- Alcohol: Standard ethanol blood tests pick up recent drinking within hours, but a specialized biomarker called phosphatidylethanol (PEth) extends detection to days or even weeks.
These ranges are approximations. A person’s weight, hydration, liver health, genetics, dose, and frequency of use all push the actual window shorter or longer. The sections below dig into specific substances where the science gets particularly interesting or where common assumptions fall short.
Cannabis and the Problem of Frequent Use
Cannabis is probably the most misunderstood substance when it comes to blood detection. Many people assume that if THC shows up in your blood, you must have used cannabis recently. For occasional users, that is roughly true: THC peaks fast and drops below detectable levels within a few hours. But for people who use cannabis regularly, the picture is very different.
A systematic review of multiple studies found that frequent cannabis users can have blood THC concentrations above 2 ng/mL even after more than four hours of abstinence. Some participants still had THC above that level after six full days without using cannabis, and a few had levels above 5 ng/mL after a day of abstinence.2Drug and Alcohol Dependence. Residual blood THC levels in frequent cannabis users after over four hours of abstinence: A systematic review THC is fat-soluble, so it accumulates in fatty tissue with repeated use and slowly leaks back into the bloodstream over time. The upshot is that a positive blood THC result in a frequent user does not necessarily mean they consumed cannabis that day.
This is a headache for law enforcement, employers, and anyone trying to use blood THC levels as a proxy for impairment. A daily user could test positive for THC during a traffic stop despite not having smoked in days, while an occasional user who smoked an hour ago might already be approaching the detection limit.
Cocaine and Its Metabolites
Cocaine itself disappears from blood quickly. After a single intranasal dose, peak concentrations in whole blood reached a median of roughly 344 ng/mL, and the parent drug’s half-life in plasma is only about an hour and a half.3PubMed. Detection of cocaine and its metabolites in whole blood and plasma following a single dose, controlled administration of intranasal cocaine That means cocaine itself can become undetectable in blood within several hours of a single use.
What lingers longer is benzoylecgonine (BZE), cocaine’s primary metabolite. Labs almost always test for BZE alongside cocaine because it persists in the body well after the parent drug is gone. In a study of repeated oral administration, the terminal elimination half-life for cocaine metabolites ranged from roughly 15 to 52 hours, and the researchers noted that cocaine accumulates in the body with chronic use, producing a prolonged elimination phase that greatly exceeds what you would see after a single dose.4PubMed. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers So while a one-time user’s blood might be clear of metabolites within a day or two, a habitual user can carry detectable levels for considerably longer.
Alcohol and the PEth Biomarker
Standard blood alcohol testing measures ethanol directly and has an extremely short detection window, typically a matter of hours after your last drink. For acute situations like emergency rooms or traffic stops, that is usually fine. But clinicians and forensic specialists sometimes need to know about drinking patterns over a longer period, and that is where phosphatidylethanol comes in.
PEth is a phospholipid that forms in red blood cell membranes only when ethanol is present. It does not occur naturally without alcohol exposure, so its presence in a blood sample is a reliable indicator that someone has been drinking. In a controlled study with 16 volunteers who drank a single dose of alcohol, PEth was detectable for 3 to 12 days afterward, with a mean half-life of about 3 days.5PubMed. Phosphatidylethanol (PEth) detected in blood for 3 to 12 days after single consumption of alcohol-a drinking study with 16 volunteers A separate clinical study found a mean half-life of about 4.6 days, though individual results ranged from 1 to 13 days.6PubMed Central. Characterization of the Pharmacokinetics of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Human Whole Blood After Alcohol Consumption in a Clinical Laboratory Study
PEth testing is increasingly used in alcohol abstinence monitoring programs and in clinical settings where a doctor needs to assess whether a patient has been drinking recently. It fills a gap that standard ethanol testing and liver enzyme tests leave open, because liver enzymes like GGT can be elevated for many reasons unrelated to alcohol.
Why Detection Times Vary So Much Between People
If you have ever searched for drug detection times online, you have probably noticed the ranges are frustratingly wide. One source says cocaine metabolites are detectable for “up to two days,” another says “up to four days.” The ranges are wide because the underlying biology is genuinely variable from person to person.
Your liver does the bulk of drug metabolism, and the enzymes responsible (primarily the cytochrome P450 family) differ between individuals due to genetics, age, overall health, and interactions with other drugs. Genetic mutations in metabolizing enzymes can alter how quickly your body clears a substance, sometimes producing effects similar to those seen in people with liver disease.7PubMed. Assessment of liver metabolic function. Clinical implications Chronic liver conditions like cirrhosis further complicate things, because they reduce metabolizing activity in uneven, unpredictable ways: one enzyme system might be severely impaired while another is still functioning.8PubMed. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
The diversity of liver enzymes and the many metabolic processes involved make it extremely difficult to predict exact clearance times for any individual using population averages.9PubMed. Liver function assessment by drug metabolism Other factors like body fat percentage (especially relevant for fat-soluble drugs like THC), kidney function, hydration status, and whether you took other drugs at the same time all shift the timeline further. The detection windows quoted in clinical references are therefore always population-level estimates, and your individual window could be meaningfully shorter or longer.
How Blood Drug Tests Work and Where They Go Wrong
Most drug testing follows a two-step process. The first step is an immunoassay, a quick, relatively inexpensive screening test. Immunoassays use antibodies designed to bind to a target drug or its metabolites. If the antibodies react above a preset threshold, the sample is flagged as “presumptive positive” and moves to a second step: a confirmatory test using more precise technology, typically some form of mass spectrometry.
The problem with immunoassays is that they are not perfectly specific. The antibodies can cross-react with other substances that have a similar molecular shape, producing false positives. For amphetamine screening, a range of prescription and over-the-counter medications can trigger a positive result, including pseudoephedrine (a common decongestant), certain beta-blockers, some antidepressants, and even metformin, a widely prescribed diabetes drug.10Current Analytical Chemistry. Common Causes of False Positive and False Negative Results in Amphetamine Screening Tests False negatives also happen, often because the drug concentration in the sample falls below the immunoassay’s cutoff threshold even though the substance is present.
Confirmatory testing with mass spectrometry is far more accurate. A study comparing immunoassay results to those from ultra-high-performance liquid chromatography with high-resolution mass spectrometry found that the advanced method produced fewer false positives and caught drugs that the immunoassay missed, with 40 false negatives and 22 false positives attributed to the immunoassay’s higher cutoff concentrations and matrix interference.11PubMed. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine This is why any consequential positive result, whether for employment, legal, or medical purposes, should always be confirmed with a second method before anyone draws conclusions.
Designer Drugs and the Limits of Standard Panels
Standard blood drug panels are designed to catch well-known substances: cannabis, cocaine, opioids, amphetamines, benzodiazepines, and sometimes a handful of others. But the landscape of recreational drugs has expanded dramatically with the rise of novel psychoactive substances, often called designer drugs or NPS. These include synthetic cannabinoids, synthetic cathinones (sometimes sold as “bath salts”), novel benzodiazepines, and various other compounds engineered to mimic the effects of traditional drugs while sidestepping existing regulations.
Standard immunoassay panels generally cannot identify these substances. To detect an NPS with an immunoassay, a lab would need to develop new antibodies specifically targeting each new compound’s molecular structure, and the market for these substances changes so rapidly that assay development cannot keep pace.12PubMed Central. Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication Specialized reference laboratories with advanced mass spectrometry equipment can identify many NPS, but turnaround times are longer and the cost is higher. In an emergency setting, this means a patient who has taken a synthetic cannabinoid might test completely negative on a standard drug panel despite being seriously intoxicated.
This gap matters clinically and legally. Emergency physicians treating a patient with altered mental status cannot always rely on the drug screen to tell them what they are dealing with, and forensic toxicologists investigating a death may need to specifically request expanded panels that go beyond the routine drugs of abuse.
How Sample Handling Affects Results
A blood test is only as good as the sample it is run on. Once blood is drawn, the drugs and metabolites inside it start to degrade, and the rate of degradation depends on the specific compound and how the sample is stored. Most common drugs are reasonably stable in blood or plasma under typical laboratory conditions, but substances with certain chemical features, particularly ester bonds or easily oxidized structures, can break down if the sample sits at room temperature for too long.13PubMed. Stability of analytes in biosamples – an important issue in clinical and forensic toxicology?
Cocaine is a textbook example. Its ester bond makes it susceptible to spontaneous hydrolysis into benzoylecgonine, which means a sample left at room temperature for hours could show a lower cocaine concentration and a higher BZE concentration than what was actually in the person’s blood at the time of the draw. Proper storage at refrigerator temperatures or below is critical to preserving the accuracy of the results.14PubMed Central. Stability of Drugs, Drug Candidates, and Metabolites in Blood and Plasma For forensic cases, where results can be challenged in court, chain-of-custody documentation and proper storage are not just best practices; they can determine whether the evidence is admissible.
Blood Tests in Legal and Forensic Settings
The legal world treats blood drug test results with more nuance than many people expect. For alcohol, there is a well-established legal threshold: 0.08 g/dL in the United States for driving under the influence. But for other drugs, setting comparable thresholds has proven essentially impossible. Researchers have argued for more than 25 years that there is no reliable blood drug concentration equivalent to the 0.08 alcohol limit, because drug tolerance, inconsistent relationships between blood concentration and impairment, the effects of drug combinations, and individual variability all make such thresholds a “mirage.”15Journal of Analytical Toxicology. The Mirage of Impairing Drug Concentration Thresholds: A Rationale for Zero Tolerance Per Se Driving under the Influence of Drugs Laws
This is one reason some jurisdictions have adopted “zero tolerance” laws for drugged driving: any detectable level of a prohibited drug in your blood constitutes a violation, regardless of whether you are actually impaired. Other jurisdictions set specific per se limits (for example, several U.S. states set a THC blood limit of 5 ng/mL), but those numbers are somewhat arbitrary given the science. As discussed earlier, a frequent cannabis user could exceed 5 ng/mL days after last using, while an occasional user might be impaired at a lower concentration.
In forensic investigations such as postmortem toxicology, blood testing gets even more complicated. After death, drugs can redistribute between tissues and blood, shifting concentrations from what they were at the time of death. A drug level measured in a postmortem blood sample may not accurately reflect the person’s antemortem exposure, which is why forensic toxicologists typically collect blood from multiple sites and interpret results cautiously.
Therapeutic Drug Monitoring Versus Toxicology Screening
Not all blood drug tests are looking for illicit use. Therapeutic drug monitoring (TDM) is a routine clinical practice where doctors order blood tests to check whether a prescribed medication is at the right level. TDM involves measuring specific drugs at timed intervals to keep the concentration in a patient’s bloodstream within a target range, optimizing the dose to maximize benefit and minimize side effects.16PubMed Central. Overview of therapeutic drug monitoring This is common for drugs with a narrow therapeutic window, where the difference between an effective dose and a toxic one is small. Anticonvulsants, certain antibiotics, lithium, and some immunosuppressants are frequently monitored this way.
TDM tests differ from toxicology screens in important ways. A toxicology screen asks “what drugs are present?” and uses broad panels to check for many substances at once. TDM asks “how much of this specific drug is present?” and uses quantitative assays calibrated to the drug being monitored. The timing of the blood draw matters too: TDM samples are often collected at “trough” levels, meaning just before the next scheduled dose, to capture the lowest concentration in the dosing cycle. If you are taking a prescribed medication and your doctor orders a blood level, that is TDM, not a drug screen, and it serves an entirely different purpose.
What a Blood Drug Test Cannot Tell You
A positive blood drug test establishes that a substance, or its metabolite, was circulating at a particular concentration at the moment the blood was drawn. It does not tell you when the drug was taken, how much was consumed, whether the person was impaired, or whether the use was medical or recreational. These limitations are sometimes overlooked in both clinical and legal contexts.
The gap between “detected” and “impaired” is real and significant. A person with a low but detectable level of a benzodiazepine in their blood might be on a stable therapeutic dose and functioning perfectly well, or they might have taken it recreationally and be dangerously sedated. The blood concentration alone does not distinguish between these scenarios, because tolerance and individual sensitivity create enormous variation in how a given blood level maps onto actual effects. This is precisely why forensic toxicologists emphasize that blood drug levels should be interpreted alongside clinical observations, behavioral assessments, and case history rather than treated as standalone evidence of impairment or intoxication.